Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation have?
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation has 499 citations in the OpenAlex counts ScholarIQ stores.
When was Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation published?
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation has 2015 year in the ScholarIQ index.
What is the open-access status of Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation?
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation has bronze oa status in the ScholarIQ index.
What is the DOI of Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation?
The DOI for Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation is on the source record.
What is the PMID of Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation?
The PMID for Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation is on the source record.
What is the OpenAlex record for Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation?
The OpenAlex for Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation is on the source record.